{"id":450443,"date":"2021-03-04T07:03:49","date_gmt":"2021-03-04T12:03:49","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=450443"},"modified":"2021-03-04T07:03:49","modified_gmt":"2021-03-04T12:03:49","slug":"bioxcel-therapeutics-to-host-fourth-quarter-and-full-year-2020-operating-and-financial-results-conference-call-and-webcast","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/bioxcel-therapeutics-to-host-fourth-quarter-and-full-year-2020-operating-and-financial-results-conference-call-and-webcast\/","title":{"rendered":"BioXcel Therapeutics to Host Fourth Quarter and Full Year 2020 Operating and Financial Results Conference Call and Webcast"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"left\">NEW HAVEN, Conn., March  04, 2021  (GLOBE NEWSWIRE) &#8212; BioXcel Therapeutics, Inc. (\u201cBioXcel\u201d or the \u201cCompany\u201d) (Nasdaq: BTAI), a clinical-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology, today announced it will host a conference call and webcast on Thursday, March 11, 2021 at 8:30 AM Eastern Time to discuss its fourth quarter and full year 2020 operating and financial results.<\/p>\n<p>\n        <strong>Conference Call &amp; Webcast Details<\/strong><br \/>\n        <br \/>\n        <strong>Date\/Time:<\/strong> Thursday, March 11, 2021, 8:30 AM Eastern Time<br \/><strong>Domestic:<\/strong> 877-407-2985<br \/><strong>International:<\/strong> 201-378-4915<\/p>\n<p>The webcast will be accessible* under &#8220;Events&#8221; on the News &amp; Media page of the Company&#8217;s website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=WHobHCWAnNcDPcoaDLvNNe9QN2kpyNk15L3Lfe7aQUjh9TPBEHN_EmfRmB6OvjOxAx7Tofai9wkvC74OIfr8mkOO01Wz8q5vaFcu1AbBXWI1vPkKh91wfX0dtPQebvme\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">www.bioxceltherapeutics.com<\/a>.<\/p>\n<p>\n        <strong>Replay<\/strong><br \/>\n        <br \/>\n        <strong>Domestic:<\/strong> 877-660-6853<br \/><strong>International:<\/strong> 201-612-7415<br \/><strong>Conference ID:<\/strong> 13716684<\/p>\n<p>*Replay available through at least March 25, 2021<\/p>\n<p>\n        <strong>BioXcel Therapeutics, Inc.<\/strong>\n      <\/p>\n<p>BioXcel Therapeutics, Inc. is a clinical stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology. BioXcel\u2019s drug re-innovation approach leverages existing approved drugs and\/or clinically validated product candidates together with big data and proprietary machine learning algorithms to identify new therapeutic indices. BioXcel\u2019s two most advanced clinical development programs are BXCL501, an investigational, proprietary, orally dissolving thin film formulation of dexmedetomidine for the treatment of agitation and opioid withdrawal symptoms, and BXCL701, an investigational, orally administered, systemic innate immunity activator in development for the treatment of aggressive forms of prostate cancer and advanced solid tumors that are refractory or treatment na\u00efve to checkpoint inhibitors. For more information, please visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=WHobHCWAnNcDPcoaDLvNNe9QN2kpyNk15L3Lfe7aQUgDC5wGY28t7AstnKjcX_LIgbl_kwDBMeAbzCDgWK5s1aPUgtKV-GClVUBZcrEHjonJfGIFSMQG00E0kZa97vjE\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">www.bioxceltherapeutics.com<\/a>.<\/p>\n<p>Contact Information:<\/p>\n<p>BioXcel Therapeutics, Inc.<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=WHobHCWAnNcDPcoaDLvNNe9QN2kpyNk15L3Lfe7aQUja1OgGvjbz5ZYXXfsArP5FcZ9TeBpPnwUCRsFtafGFpv8_j3-a_zjISflHpMxXAI3Ivvfyl6Z-owEL2_uSGujS\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">www.bioxceltherapeutics.com<\/a><\/p>\n<p>Investor Relations:<br \/>Mary Coleman<br \/>BioXcel Therapeutics, VP of Investment Relations<br \/>MColeman@bioxceltherapeutics.com<br \/>1.475.238.6837<\/p>\n<p>John Graziano<br \/>Solebury Trout<br \/>jgraziano@soleburytrout.com<br \/>1.646.378.2942<\/p>\n<p>Media:<\/p>\n<p>Julia Deutsch<br \/>Solebury Trout<br \/>jdeutsch@soleburytrout.com<br \/>1.646.378.2967<\/p>\n<p>      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4NDE4MyM0MDQ3NzA0IzIxOTI5NTc=\" width=\"1\" height=\"1\" \/><br \/>\n      <br \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/ml.globenewswire.com\/release\/track\/ec00bd77-34ff-4ff7-a38b-f28c80311abf\" width=\"1\" height=\"1\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>NEW HAVEN, Conn., March 04, 2021 (GLOBE NEWSWIRE) &#8212; BioXcel Therapeutics, Inc. (\u201cBioXcel\u201d or the \u201cCompany\u201d) (Nasdaq: BTAI), a clinical-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology, today announced it will host a conference call and webcast on Thursday, March 11, 2021 at 8:30 AM Eastern Time to discuss its fourth quarter and full year 2020 operating and financial results. Conference Call &amp; Webcast Details Date\/Time: Thursday, March 11, 2021, 8:30 AM Eastern TimeDomestic: 877-407-2985International: 201-378-4915 The webcast will be accessible* under &#8220;Events&#8221; on the News &amp; Media page of the Company&#8217;s website at www.bioxceltherapeutics.com. Replay Domestic: 877-660-6853International: 201-612-7415Conference ID: 13716684 *Replay available through at least March 25, 2021 BioXcel Therapeutics, Inc. BioXcel &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/bioxcel-therapeutics-to-host-fourth-quarter-and-full-year-2020-operating-and-financial-results-conference-call-and-webcast\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;BioXcel Therapeutics to Host Fourth Quarter and Full Year 2020 Operating and Financial Results Conference Call and Webcast&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-450443","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>BioXcel Therapeutics to Host Fourth Quarter and Full Year 2020 Operating and Financial Results Conference Call and Webcast - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/bioxcel-therapeutics-to-host-fourth-quarter-and-full-year-2020-operating-and-financial-results-conference-call-and-webcast\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"BioXcel Therapeutics to Host Fourth Quarter and Full Year 2020 Operating and Financial Results Conference Call and Webcast - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"NEW HAVEN, Conn., March 04, 2021 (GLOBE NEWSWIRE) &#8212; BioXcel Therapeutics, Inc. (\u201cBioXcel\u201d or the \u201cCompany\u201d) (Nasdaq: BTAI), a clinical-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology, today announced it will host a conference call and webcast on Thursday, March 11, 2021 at 8:30 AM Eastern Time to discuss its fourth quarter and full year 2020 operating and financial results. Conference Call &amp; Webcast Details Date\/Time: Thursday, March 11, 2021, 8:30 AM Eastern TimeDomestic: 877-407-2985International: 201-378-4915 The webcast will be accessible* under &#8220;Events&#8221; on the News &amp; Media page of the Company&#8217;s website at www.bioxceltherapeutics.com. Replay Domestic: 877-660-6853International: 201-612-7415Conference ID: 13716684 *Replay available through at least March 25, 2021 BioXcel Therapeutics, Inc. BioXcel &hellip; Continue reading &quot;BioXcel Therapeutics to Host Fourth Quarter and Full Year 2020 Operating and Financial Results Conference Call and Webcast&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/bioxcel-therapeutics-to-host-fourth-quarter-and-full-year-2020-operating-and-financial-results-conference-call-and-webcast\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-03-04T12:03:49+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4NDE4MyM0MDQ3NzA0IzIxOTI5NTc=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bioxcel-therapeutics-to-host-fourth-quarter-and-full-year-2020-operating-and-financial-results-conference-call-and-webcast\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bioxcel-therapeutics-to-host-fourth-quarter-and-full-year-2020-operating-and-financial-results-conference-call-and-webcast\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"BioXcel Therapeutics to Host Fourth Quarter and Full Year 2020 Operating and Financial Results Conference Call and Webcast\",\"datePublished\":\"2021-03-04T12:03:49+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bioxcel-therapeutics-to-host-fourth-quarter-and-full-year-2020-operating-and-financial-results-conference-call-and-webcast\\\/\"},\"wordCount\":287,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bioxcel-therapeutics-to-host-fourth-quarter-and-full-year-2020-operating-and-financial-results-conference-call-and-webcast\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODE4NDE4MyM0MDQ3NzA0IzIxOTI5NTc=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bioxcel-therapeutics-to-host-fourth-quarter-and-full-year-2020-operating-and-financial-results-conference-call-and-webcast\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bioxcel-therapeutics-to-host-fourth-quarter-and-full-year-2020-operating-and-financial-results-conference-call-and-webcast\\\/\",\"name\":\"BioXcel Therapeutics to Host Fourth Quarter and Full Year 2020 Operating and Financial Results Conference Call and Webcast - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bioxcel-therapeutics-to-host-fourth-quarter-and-full-year-2020-operating-and-financial-results-conference-call-and-webcast\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bioxcel-therapeutics-to-host-fourth-quarter-and-full-year-2020-operating-and-financial-results-conference-call-and-webcast\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODE4NDE4MyM0MDQ3NzA0IzIxOTI5NTc=\",\"datePublished\":\"2021-03-04T12:03:49+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bioxcel-therapeutics-to-host-fourth-quarter-and-full-year-2020-operating-and-financial-results-conference-call-and-webcast\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bioxcel-therapeutics-to-host-fourth-quarter-and-full-year-2020-operating-and-financial-results-conference-call-and-webcast\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bioxcel-therapeutics-to-host-fourth-quarter-and-full-year-2020-operating-and-financial-results-conference-call-and-webcast\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODE4NDE4MyM0MDQ3NzA0IzIxOTI5NTc=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODE4NDE4MyM0MDQ3NzA0IzIxOTI5NTc=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bioxcel-therapeutics-to-host-fourth-quarter-and-full-year-2020-operating-and-financial-results-conference-call-and-webcast\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"BioXcel Therapeutics to Host Fourth Quarter and Full Year 2020 Operating and Financial Results Conference Call and Webcast\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"BioXcel Therapeutics to Host Fourth Quarter and Full Year 2020 Operating and Financial Results Conference Call and Webcast - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/bioxcel-therapeutics-to-host-fourth-quarter-and-full-year-2020-operating-and-financial-results-conference-call-and-webcast\/","og_locale":"en_US","og_type":"article","og_title":"BioXcel Therapeutics to Host Fourth Quarter and Full Year 2020 Operating and Financial Results Conference Call and Webcast - Market Newsdesk","og_description":"NEW HAVEN, Conn., March 04, 2021 (GLOBE NEWSWIRE) &#8212; BioXcel Therapeutics, Inc. (\u201cBioXcel\u201d or the \u201cCompany\u201d) (Nasdaq: BTAI), a clinical-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology, today announced it will host a conference call and webcast on Thursday, March 11, 2021 at 8:30 AM Eastern Time to discuss its fourth quarter and full year 2020 operating and financial results. Conference Call &amp; Webcast Details Date\/Time: Thursday, March 11, 2021, 8:30 AM Eastern TimeDomestic: 877-407-2985International: 201-378-4915 The webcast will be accessible* under &#8220;Events&#8221; on the News &amp; Media page of the Company&#8217;s website at www.bioxceltherapeutics.com. Replay Domestic: 877-660-6853International: 201-612-7415Conference ID: 13716684 *Replay available through at least March 25, 2021 BioXcel Therapeutics, Inc. BioXcel &hellip; Continue reading \"BioXcel Therapeutics to Host Fourth Quarter and Full Year 2020 Operating and Financial Results Conference Call and Webcast\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/bioxcel-therapeutics-to-host-fourth-quarter-and-full-year-2020-operating-and-financial-results-conference-call-and-webcast\/","og_site_name":"Market Newsdesk","article_published_time":"2021-03-04T12:03:49+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4NDE4MyM0MDQ3NzA0IzIxOTI5NTc=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bioxcel-therapeutics-to-host-fourth-quarter-and-full-year-2020-operating-and-financial-results-conference-call-and-webcast\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bioxcel-therapeutics-to-host-fourth-quarter-and-full-year-2020-operating-and-financial-results-conference-call-and-webcast\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"BioXcel Therapeutics to Host Fourth Quarter and Full Year 2020 Operating and Financial Results Conference Call and Webcast","datePublished":"2021-03-04T12:03:49+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bioxcel-therapeutics-to-host-fourth-quarter-and-full-year-2020-operating-and-financial-results-conference-call-and-webcast\/"},"wordCount":287,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bioxcel-therapeutics-to-host-fourth-quarter-and-full-year-2020-operating-and-financial-results-conference-call-and-webcast\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4NDE4MyM0MDQ3NzA0IzIxOTI5NTc=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bioxcel-therapeutics-to-host-fourth-quarter-and-full-year-2020-operating-and-financial-results-conference-call-and-webcast\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/bioxcel-therapeutics-to-host-fourth-quarter-and-full-year-2020-operating-and-financial-results-conference-call-and-webcast\/","name":"BioXcel Therapeutics to Host Fourth Quarter and Full Year 2020 Operating and Financial Results Conference Call and Webcast - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bioxcel-therapeutics-to-host-fourth-quarter-and-full-year-2020-operating-and-financial-results-conference-call-and-webcast\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bioxcel-therapeutics-to-host-fourth-quarter-and-full-year-2020-operating-and-financial-results-conference-call-and-webcast\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4NDE4MyM0MDQ3NzA0IzIxOTI5NTc=","datePublished":"2021-03-04T12:03:49+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bioxcel-therapeutics-to-host-fourth-quarter-and-full-year-2020-operating-and-financial-results-conference-call-and-webcast\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/bioxcel-therapeutics-to-host-fourth-quarter-and-full-year-2020-operating-and-financial-results-conference-call-and-webcast\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bioxcel-therapeutics-to-host-fourth-quarter-and-full-year-2020-operating-and-financial-results-conference-call-and-webcast\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4NDE4MyM0MDQ3NzA0IzIxOTI5NTc=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4NDE4MyM0MDQ3NzA0IzIxOTI5NTc="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bioxcel-therapeutics-to-host-fourth-quarter-and-full-year-2020-operating-and-financial-results-conference-call-and-webcast\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"BioXcel Therapeutics to Host Fourth Quarter and Full Year 2020 Operating and Financial Results Conference Call and Webcast"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/450443","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=450443"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/450443\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=450443"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=450443"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=450443"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}